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Abstract
Background: Cultured sensory neurons are a common experimental model to elucidate the molecular
mechanisms of pain transduction typically involving activation of ATP-sensitive P2X or capsaicin-sensitive
TRPV1 receptors. This applies also to trigeminal ganglion neurons that convey pain inputs from head
tissues. Little is, however, known about the plasticity of these receptors on trigeminal neurons in culture,
grown without adding the neurotrophin NGF which per se is a powerful algogen. The characteristics of
such receptors after short-term culture were compared with those of ganglia. Furthermore, their
modulation by chronically-applied serotonin or NGF was investigated.
Results: Rat or mouse neurons in culture mainly belonged to small and medium diameter neurons as
observed in sections of trigeminal ganglia. Real time RT-PCR, Western blot analysis and
immunocytochemistry showed upregulation of P2X3 and TRPV1 receptors after 1–4 days in culture
(together with their more frequent co-localization), while P2X2 ones were unchanged. TRPV1
immunoreactivity was, however, lower in mouse ganglia and cultures. Intracellular Ca2+ imaging and whole-
cell patch clamping showed functional P2X and TRPV1 receptors. Neurons exhibited a range of responses
to the P2X agonist α, β-methylene-adenosine-5'-triphosphate indicating the presence of homomeric P2X3
receptors (selectively antagonized by A-317491) and heteromeric P2X2/3 receptors. The latter were
observed in 16 % mouse neurons only. Despite upregulation of receptors in culture, neurons retained the
potential for further enhancement of P2X3 receptors by 24 h NGF treatment. At this time point TRPV1
receptors had lost the facilitation observed after acute NGF application. Conversely, chronically-applied
serotonin selectively upregulated TRPV1 receptors rather than P2X3 receptors.
Conclusion: Comparing ganglia and cultures offered the advantage of understanding early adaptive
changes of nociception-transducing receptors of trigeminal neurons. Culturing did not prevent differential
receptor upregulation by algogenic substances like NGF or serotonin, indicating that chronic application
led to distinct plastic changes in the molecular mechanisms mediating pain on trigeminal nociceptors.
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Trigeminal ganglion (TG) neurons convey sensory inputs
including painful stimuli from head tissues like skin and
mucosal surfaces, tooth pulp and meninges. The charac-
terization of nociception-transducing receptors on TG
neurons thus becomes important to understand certain
forms of acute and chronic pain.
Important pain transducers of noxious stimuli are small
and medium size neurons (nociceptors) that can express
ATP-activated P2X3 subunit-containing receptors and/or
capsaicin (and heat) sensitive TRPV1 receptors [1,2]. Acti-
vation of TRPV1 receptors is associated with a slow inward
current [1] while ionotropic ATP receptors generate fast
currents mediated by P2X3 receptors, and slow ones medi-
ated by P2X2 subunit-containing receptors [3,4]. Over-
expression of heteromeric P2X2/3 receptors is suggested to
be associated with chronic pain states [2,5].
To understand the molecular basis of chronic pain, it
would be helpful to use TG neurons in culture as models
to study slow changes in the structure and function of P2X
or TRPV1 receptors after exposure to mediators such as
serotonin or NGF to mimic certain forms of chronic head-
ache [6].
TG nociceptive neurons are modulated by serotonin (5-
HT) in a complex fashion. In fact, 5-HT can excite them
through 5-HT3 receptors [7] as well as depress their pain
signaling via multiple subtypes of the 5-HT1 receptor
group [8], an action which had led to the clinical use of 5-
HT1 receptor agonists to treat migraine. Furthermore,
acute application of 5-HT can strongly potentiate
responses mediated by TRPV1 receptors, indicating rapid
nociceptive sensitization [9]. Nevertheless, headache is
usually a sustained form of pain and its molecular mech-
anisms including the modulatory action of 5-HT on pain
signaling by TG neurons should be studied with long-
term experimental models.
NGF may be an additional contributor to headache
because of its increased levels in the cerebrospinal fluid of
patients during headache attacks [10]. Application of NGF
sensitizes spike firing and TRPV1 receptor activity of dor-
sal root ganglion (DRG) neurons [1,43] and facilitates
release of algogenic substances like CGRP from TG neu-
rons [11].
To the best of our knowledge, there is no information on
the evolution of TG pain receptors (ATP P2X or TRPV1
ones) during culture since previous studies have simply
investigated nociceptors after they had been plated for cul-
ture [4,6,12]. Thus, the current study characterized the
expression, distribution and function of ATP P2X and
TRPV1 receptors in cultured trigeminal neurons in com-
parison with ganglia. We chose to study rat and mouse
neurons because the former had been used in other stud-
ies of pain and the latter can provide fundamental new
data concerning genetic models of chronic pain. While
information concerning P2X receptors in TG is less abun-
dant than those for DRG, it is clear that extrapolating data
from DRG to TG is inadvisable in view of the very differ-
ent distribution, expression and modulation of P2X3
receptors between these ganglia [13].
Using TG preparations, we addressed the following ques-
tions: 1. How do P2X and TRPV1 receptors of rat or mouse
TG neurons grown in culture compare with those of gan-
glia? 2. Are these markers stable in culture and are they
functional? 3. Are these pain receptors similar in rat and
mouse TGs? 4. Can 5-HT or NGF modulate the function
of P2X and TRPV1 receptors on cultured TG neurons? We
report significant differences in the expression and phar-
macological modulation of P2X and TRPV1 receptors of
nociceptive neurons cultured from rat or mouse TGs.
Results
Rat and mouse neurons are stable in culture without 
adding NGF
Scanning electron microscopy was used to investigate if
the surface ultrastructure of rat or mouse TG neurons had
changed after 24 h in culture. After enzymatic dissection
of the ganglion at one d in culture, rat or mouse TG neu-
rons retained their spherical shape with somewhat irregu-
lar contour probably resulting from the detachment of
satellite cells. The surface of TG neurons in culture was
characterized by the presence of small microvilli of differ-
ent length (200–500 nm) emerging from cell body as well
Survival of neurons in TG ganglia or in cultureFigure 1
Survival of neurons in TG ganglia or in culture. Sur-
vival of neurons (calculated as neuron density expressed as 
number of β-tubulinIII positive cells per unit area) at 1–4 days 
in culture. Data are normalized with respect to those at 1 
day (n = 250). *: P < 0.05.Page 2 of 15
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section of 120 nm) that remained in contact with the neu-
ron surface for their entire length. These morphological
features of TG neurons are typical of rat sensory neurons
[14], confirming that culturing conditions without exoge-
nous NGF did not change neuronal phenotype.
Rat β-tubulinIII positive cells demonstrated good viability
in vitro (<30 % loss at 4 d; Fig. 1, left, in which data
expressed as neuronal density per unit area are normal-
ized with respect to the number of neurons found at 24 h
in culture). Mouse neurons were more labile as their
number was more consistently reduced after the second d
in culture (Fig. 1, right). Nevertheless, at each one of the
four days in culture, only 3–10 % of total mouse neurons
was labeled with antibodies against early markers of
apoptosis as JNK or activated caspase3 (not shown).
Apoptotic nuclei were also rarely detected.
mRNA and protein expression
We next assessed if rat and mouse TG neurons in culture
demonstrated changes in the levels of mRNA transcripts
of P2X and TRPV1 receptors with respect to the ganglion.
To quantify changes in neuron specific mRNA neosynthe-
sis for P2X and TRPV1 receptors in culture with respect to
the ganglion, we performed real time RT-PCR experiments
as a sensitive method to detect changes in gene expression
[15]. Fig 2A shows that, when comparing samples con-
taining an equal amount of the housekeeping gene
GAPDH mRNA, there was significant upregulation of
P2X3 and TRPV1 transcripts for rat and mouse neurons in
vitro with respect to the ganglion after normalization for
the neuronal-specific β-tubulinIII marker. In particular,
P2X3 mRNA showed a peak at 24 h (1.29 fold, P < 0.05,
and 1.39 fold, P < 0.01, for rat and mouse, respectively).
Rat TRPV1 mRNA analysis showed a peak at 48 h (1.4
fold, P < 0.01), while in the mouse TRPV1 mRNA
increased more substantially (1.9 fold, P < 0.001) already
at the first d and remained elevated for the following two
days. P2X2 mRNA signals did not show any significant
change.
Because P2X2 and TRPV1 receptors are also expressed in
non-neuronal cells, while the P2X3 receptor is not [16,17],
it was important to assess the contribution of P2X2, P2X3
and TRPV1 mRNAs in 3 week-old cultures, containing no
neurons (β-tubulinIII mRNA negative). Real time amplifi-
cation experiments showed that equivalent amount of
samples (measured as GAPDH mRNA amplification lev-
els) gave undetectable amplification of P2X2, P2X3 and
TRPV1 mRNAs, indicating that the contribution of non-
neuronal mRNAs to PCR experiments was minimal.
Western immunoblotting experiments were performed to
investigate protein expression levels for P2X3, P2X2 and
TRPV1 receptors in rat and mouse ganglia as well in cul-
ture (Fig. 2B). To study the time course of the protein
expression profiles in culture and in the ganglion, we
investigated differences in the mature form of rat P2X3,
P2X2 and TRPV1 receptors (bands at 57, 65, 120 kDa)
under equal protein loading conditions assessed with β-
tubulinIII staining (Fig. 2B, a and Fig. 2C). While in the
Real time RT-PCR and western immunoblot of ganglia and culturesFig  2
Real time RT-PCR and western immunoblot of gan-
glia and cultures. A, real time RT-PCR of ganglia and cul-
tures from rat and mouse. Ordinate: relative increment with 
respect to the ganglion products. For each receptor, amplifi-
cation values were normalized with β-tubulinIII mRNA levels 
and compared with the ganglion mRNA levels. GAPDH 
amplification control was the same in all reactions. B, west-
ern immunoblots of equal amounts of neuronal protein 
lysates (β-tubulinIII) derived from ganglia or culture. Immun-
odetection of P2X3, P2X2 and TRPV1 mature proteins 
revealed proper migration (a) in accordance with Vulchanova 
et al.[53] for the predominant P2X3 form (57 kDa), with 
Newbolt et al. [54] for the P2X2 mature receptor (65 kDa) 
and with Kedei et al. [55] for the TRPV1 mature receptor 
(120 kDa). Panel B b shows P2X3 native (45 kDa) and inter-
mediate polypeptides (up to 50 kDa) detected one d in cul-
ture (1) but not in the ganglion (T) as reported by Nicke et 
al. [56] C, relative optical density values of mature receptors 
at 1–4 days in culture (normalized with respect to β-tubuli-
nIII) and compared to ganglion values. For all experiments 
shown in A-C n = 3 animals for ganglion or day in culture 
datapoint (each point is mean ± SEM). *: P < 0.05; **: P < 
0.01.Page 3 of 15
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ment already at 24 h in culture (1.5 fold, P < 0.05), this
was not paralleled by P2X2 and P2X3 expression that
showed no substantial change in culture with respect to
ganglion (Fig. 2C). Note that the 120 kDa TRPV1 protein
was more prominent in culture than in the ganglion (Fig.
2B a). Moreover, in the case of the P2X3 receptor, interme-
diate bands (45–55 kDa) were observed in culture but not
in the ganglia (Fig. 2B b), indicating that, despite a con-
stant amount of the mature 57 kDa protein, there was a
significant increment of P2X3 protein expression occur-
ring in culture (2.0 fold, P < 0.05). Analysis of mouse 1–3
d cultures revealed similar protein expression behaviour
(not shown). The different time profile of data related to
TRPV1 expression obtained with real time RT-PCR and
western blotting might have been due to a rapid increase
in protein translation rate dependent on already present
mRNA as reported for the same protein in DRG neurons
in vitro [18]. Immunocytochemical analysis was then car-
ried out to further investigate changes in receptor protein
expression in culture.
Immunoreactivity of TG neurons
The distribution among rat and mouse neurons of P2X3,
P2X2 and TRPV1 receptors in freshly excised ganglia and
TG cultures was studied as shown by the example of Fig.
3A in which rat ganglion immunoreactivity for P2X3
receptors is compared with 1 d cultured neurons. Neurons
labeled by the P2X3 antibody were clearly detected, as
much as neurons immunoreactive for TRPV1 receptors
(right panel). Fig. 3B quantifies the percentage of TG neu-
rons immunoreactive for P2X3, P2X2 and TRPV1 receptors
under different experimental conditions. P2X2 receptors
in both rat and mouse TGs were equally represented in
ganglion and in culture (approximately 40 %). The
number of rat and mouse P2X3 or TRPV1 immunoreactive
neurons grew by about 20% with respect to the ganglion
(see Fig. 3). Fig. 3C shows that the considerable difference
between mouse and rat neurons expressing TRPV1 recep-
tors in culture was not simply due to the in vitro condition:
in fact, TRPV1 expressing neurons were clearly more
abundant in rat ganglia than in mouse ones as quantified
by comparing histograms in Fig. 3B.
Table 1 presents pooled data for the distribution of these
receptors among rat and mouse neurons of different
somatic diameter in the ganglion or in culture. P2X3, P2X2
and TRPV1 receptors were expressed by all three subpop-
ulations of TG neurons (small, medium and large size
cells) in the ganglion. It is noteworthy that the relative
numbers of neurons expressing these receptors showed
only minimal variations in culture (Table 1). Despite an
increment in the P2X3 immunopositive cells in culture,
P2X3 was predominantly confined to small size neurons
for both rat and mouse (60%). In culture, P2X2 was
expressed predominantly in medium (50%) while TRPV1
in small size neurons (65–70%). These values remained
virtually unchanged during the time in vitro.
Receptor co-expression
We next studied the co-existence of two markers on same
neurons. Pooled data are given in Fig. 4. Notwithstanding
a large number of neurons co-expressing two markers, it
was apparent that the number of P2X3 positive cells also
positive for P2X2 receptors was higher in rat than in mouse
cultures (53% vs 35%, respectively), a phenomenon
observed also on ganglion tissue (63% vs 40%, respec-
tively). Likewise, P2X3 positive cells had a higher proba-
bility of expressing TRPV1 receptors in rat than in mouse
culture (75% vs 54%), a result confirmed with rat and
mouse ganglia (61 and 43%, respectively). Although the
global number of P2X2 receptor expressing neurons was
always comparatively low (see Fig. 3 and Table 1), once in
culture, the percentage of P2X2-positive neurons express-
ing also P2X3 receptors largely rose. A strong rise in the
number of TRPV1-positive neurons that could also co-
express P2X3 receptors occurred in rat TG culture and, less
intensely, in mouse TG culture.
Calcium imaging of TG neurons
To characterize the functional properties of a large
number of intact (non-patched) neurons, we first per-
formed intracellular Ca2+-imaging of 24 h cultured TG
neurons activated by agonists of P2X3 and TRPV1 recep-
tors as this method is a potent screening tool for P2X
receptor assay [19]. As a pharmacological tool to differen-
tiate between P2X2 and P2X3 receptors and to avoid activa-
tion of metabotropic P2Y receptors that are natively
expressed by TG neurons [20], we used α, β-methylene-
adenosine 5'-triphosphate (α, β-meATP), a selective ago-
nist for P2X3 (and P2X1) subunit-containing receptors
[16], and capsaicin to activate TRPV1 receptors [21].
Neurons were identified by their responsiveness to pulses
of KCl (15 or 50 mM; 1 s). Fig. 5A shows examples of Ca2+
transients in mouse TG neurons following 2 s application
of 10 µM α, β-meATP or 1 µM capsaicin. Note that capsa-
icin-induced transients were often long lasting (see exam-
ple in Fig. 5A b). KCl-sensitive cells could be classified
into three groups: 1. responsive to α, β-meATP only
('purinergic phenotype'; Fig. 5A a); 2. responsive to capsa-
icin only ('vanilloid phenotype'; Fig. 5A b); 3. responsive
to both agonists ('mixed phenotype'; Fig. 5A c). Figure 5B
summarizes results obtained from 346 mouse and 41 rat
TG neurons. In agreement with our immunocytochemis-
try results, most (68%) mouse neurons responded to α, β-
meATP (regardless of their sensitivity to capsaicin), and
33% responded to capsaicin (regardless of their sensitivity
to α, β-meATP). Twenty percent of mouse neurons
responded to both drugs. Interestingly, the fraction of ratPage 4 of 15
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as in the mouse, while the percentage of cells responding
to capsaicin was higher (55%). The fraction of rat cells
sensitive to both agonists was 44% (Fig. 5B). To sum up,
imaging data from intact neurons validated the molecular
biology and immunocytochemical profile of mouse and
rat TG neurons.
P2X or TRPV1 receptor-mediated currents generated by 
TG neurons in culture
Since in various tissues there are differences in P2X recep-
tor function between rat and mouse cells [22,23], patch
clamp recording was used to further characterize receptor-
mediated currents of rat or mouse TG neurons (small and
medium size).
Fig. 6A shows typical examples of the currents induced by
agonists of P2X3-containing or TRPV1 receptors. Applica-
tion (2 s) of α, β-meATP (10 µM) to either rat or mouse
neurons (top row) elicited a fast-developing inward cur-
rent, which peaked and then strongly desensitized during
agonist application, a behavior typical of currents medi-
ated mainly by P2X3 receptors [16]. Plots of peak ampli-
tude responses versus increasing concentrations of α, β-
meATP are depicted in Figure 6B. For both species the
plots attained analogous maximum response, and the
EC50 values for α, β-meATP were almost the same in both
species (5 ± 1 µM for rat neurons, n = 9, and 6 ± 1 µM for
mouse neurons, n = 12). This observation is consistent
with the realization that P2X3 receptors of rat and mouse
share 98.7% identity of their primary sequence (Blast
analysis: [NP_663501] and [NP_112337] for mouse and
rat receptors, respectively).
Since one characteristic feature of P2X3-containing recep-
tors is their fast-developing desensitization [16], the cur-
rent decay during application of α, β-meATP (10 µM, 2 s)
was also analyzed. The rapid phase of current decay could
be fitted monoexponentially with a time constant (τfast)
which was the same for rat and mouse cells (44 ± 3 ms and
48 ± 3 ms for rat and mouse; n = 24 and 39, respectively),
indicating that the onset of fast desensitization was the
same for both species.
While α, β-meATP activates homomeric P2X3 receptors
and has no effect on homomeric P2X2 receptors [16], this
agonist can also activate heteromeric P2X2/3 receptors with
characteristically-slow current decay during agonist appli-
cation [24,25]. Thus, co-activation of P2X3 and P2X2/3
receptors would produce mixed responses with a fast peak
and a residual current [24,25]. One index for the presence
of heteromeric P2X2/3 receptors on TG neurons was con-
sidered the presence of a residual current (Iresidual in inset
to Fig. 6C) at the end of a 2 s-long α, β-meATP application
(10 µM). Iresidual was significantly (P < 0.01) different
between rat and mouse neurons at 24 h in culture (-73 ±
22 pA, n = 27, and -15 ± 3 pA, n = 41 for rat and mouse
cells, respectively). It was interesting to examine how
many neurons would express responses indicative of
heteromeric receptors. This issue is shown in Fig. 6C with
P2X and TRPV1 immunoreactivity in ganglia and culturesFigure 3
P2X and TRPV1 immunoreactivity in ganglia and cul-
tures. A, example of P2X3 receptor expression by β-tubuli-
nIII labeled neurons in a fixed ganglion (left; calibration bar = 
50 µm). After one day in culture, medium-size neurons that 
are also labeled by β-tubulinIII are immunoreactive for P2X3 
(middle) or TRPV1 (right; calibration bar = 50 µm) recep-
tors. B, percentage of neurons (β-tubulinIII positive) immu-
noreactive for P2X3, P2X2 and TRPV1 in the ganglion and at 
different d in culture, for rat (left) and mouse (right; n = 3 
animals in all cases). The number of P2X3 and TRPV1 immu-
noreactive neurons increase significantly after dissection and 
remain constant in culture, while P2X2 receptor labeled neu-
rons remain unchanged. *: P < 0.05 for indicated pair of his-
tograms. Values at later d in culture are also significantly 
different from ganglia. C, comparison of TRPV1 receptor 
immunoreactivity of rat (left) or mouse (right) ganglia. Note 
larger number of immunoreactive neurons in the rat tissue. 
Calibration bars = 50 µm.Page 5 of 15
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for rat (filled bars) and mouse (grey bars) neurons. We
assumed that currents comprising Iresidual at least 5 % of
Ipeak were suggestive of heteromeric P2X2/3 receptors (ver-
tical dashed line in Fig. 6C) because, under the present
conditions, α, β-meATP was a selective agonist for P2X3
subunit-containing receptors. Using this criterion [26], 54
% of rat neurons generated mixed currents, while only 16
% of mouse neurons did so. These data suggested that α,
β-meATP-mediated responses comprised a limited contri-
bution by heteromeric P2X2/3 receptors. This notion was
further supported by experiments with the selective P2X3
receptor antagonist A-317491 (1 µM; [27]) that almost
completely abolished (5 ± 1 %; n = 13) the currents
induced by α, β-meATP, confirming that P2X3 receptors
were the target for the action of α, β-meATP.
Since approximately 40 % TG neurons were immunopos-
itive for P2X2 subunits (Fig. 3B), we further explored the
functional role of this subunit by comparing currents
evoked by ATP with those induced by α, β-meATP (as the
latter is ineffective on P2X2 receptors). On the same
mouse TG neurons (24 h in culture), 10 µM ATP elicited
currents with peak amplitude significantly larger (131 ± 9
%; P < 0.05) that the ones produced by α, β-meATP (n =
27). Interestingly, taking the criterion of 5 % size of Iresid-
ual, while 3/27 neurons generated Iresidual in response to α,β-meATP, 10/27 produced a slow current to ATP applica-
tion.
Fig. 7A summarizes the proportion of rat and mouse cells
(24 h in culture) responding to a test concentration of α,
β-meATP or capsaicin. In the case of rat neurons, the
number of cells sensitive to α, β-meATP was about 80 %,
while 60 % responded to capsaicin. The percent value of
Table 1: P2X or TRPV1 of small, medium and large TG neurons in ganglia or in culture
P2X3
Rat Mouse
Small Medium Large Small Medium Large
Tissue 44 ± 4% 33 ± 3% 23 ± 4% 49 ± 3% 36 ± 4% 15 ± 4%
24 h 55 ± 3% 28 ± 3% 17 ± 2% 60 ± 4% 31 ± 3% 9 ± 2%
48 h 54 ± 2% 33 ± 3% 13 ± 3% 56 ± 4% 29 ± 3% 15 ± 2%
72 h 58 ± 5% 30 ± 4% 12 ± 2% 62 ± 5% 30 ± 4% 8 ± 2%
96 h 56 ± 4% 31 ± 4% 13 ± 3% 60 ± 4% 33 ± 3% 7 ± 2%
P2X2
Rat Mouse
Small Medium Large Small Medium Large
Tissue 30 ± 2% 55 ± 3% 15 ± 4% 32 ± 3% 52 ± 2% 16 ± 4%
24 h 34 ± 4% 56 ± 3% 10 ± 4% 36 ± 2% 51 ± 3% 13 ± 3%
48 h 36 ± 4% 57 ± 4% 7 ± 3% 29 ± 3% 55 ± 3% 16 ± 4%
72 h 33 ± 3% 57 ± 4% 10 ± 3% 22 ± 3% 65 ± 2% 13 ± 3%
96 h 34 ± 3% 60 ± 2% 6 ± 3% 21 ± 3% 69 ± 6% 10 ± 3%
TRPV1
Rat Mouse
Small Medium Large Small Medium Large
Tissue 60 ± 3% 31 ± 4% 9 ± 3% 59 ± 2% 32 ± 3% 9 ± 2%
24 h 65 ± 4% 29 ± 4% 6 ± 2% 66 ± 2% 31 ± 3% 3 ± 1%
48 h 64 ± 2% 29 ± 3% 7 ± 2% 70 ± 3% 28 ± 3% 2 ± 1%
72 h 66 ± 4% 29 ± 2% 5 ± 2% 68 ± 5% 30 ± 4% 2 ± 1%
96 h 68 ± 4% 27 ± 2% 5 ± 2% 72 ± 4% 26 ± 3% 2 ± 1%
Data are % distribution of P2X3, P2X2 or TRPV1 immunopositive neurons according to their somatic size (small: dia <15 µm; medium: 15 µm–25 µm; large: dia > 25 µm). In each box 100% = the total number of cells immunoreactive for the given receptor.Page 6 of 15
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case of mouse TG cells, approximately 80 % of neurons
were activated by α, β-meATP, while about 20 %
responded to capsaicin and only a small minority of neu-
rons could respond to capsaicin as well as to α, β-meATP.
The next issue was the stability of functional receptors
during culturing conditions. This was examined with rat
TG neurons as shown in Fig. 7B a (filled bars) where the
fraction of cells responding to α, β-meATP was large after
24 h in culture and only slightly increased later. The peak
amplitude of their response, however, remained essen-
tially unchanged (Fig. 7B b, filled bars). The number of
cells responsive to capsaicin was, however, smaller and
remained at a relatively steady level in culture (Fig. 7B a,
grey bars), as the apparent decrease in response amplitude
was not statistically significant (Fig. 7B b, grey bars).
Chronically-applied NGF differentially modulated P2X3 
and TRPV1 receptors
Although exogenous NGF is often used to grow sensory
neurons in culture [4,12,28], we decided as a routine to
avoid adding NGF to the medium because it is a potent
algogenic substance and might thus alter the phenotype
and function of pain receptors [1]. An ELISA bioassay was
performed to measure the amount of NGF in the bulk
medium of TG neurons after 24 h in culture. In rat and
mouse culture medium NGF concentrations were 9.1 ±
1.3 and 12.5 ± 3.1 pg/ml (absolute concentrations were
6.4 ± 1.5 and 13.4 ± 1.7 pg, respectively): these values are
not distant from the binding dissociation constant (0.6
nM) for the high affinity NGF receptor [29], especially
when considering the large dilution in the bulk solution.
Endogenous NGF was also detected in homogenates of
ganglia or cells after 24 h in culture. Indeed, NGF was
more concentrated in cultured cells (rat cultures = 19.5 ±
0.9 pg/µg of DNA content, n = 3 cultures; mouse cultures
= 23.3 ± 2.2 pg/µg; n = 4) than in the whole ganglion (rat
ganglia = 11.4 ± 1.1, n = 3 rats; mouse ganglia = 12.7 ± 0.1,
n = 4).
We next investigated what effects a dose of 50 ng/ml of
NGF [12] applied for 24 h may produce on the function
of P2X3 and TRPV1 receptors of mouse TG neurons. As a
screening assay we first assessed changes in the percent of
neurons responsive to α, β-meATP (10 µM) in terms of
Ca2+ transients: Fig. 8A a shows that, after NGF applica-
tion, their number became significantly larger. Con-
versely, the fraction of neurons responsive to capsaicin (1
µM) remained unchanged (Fig. 8A b). These data were
expanded with patch clamp investigations as indicated by
the examples of Fig. 8B a that depicts larger membrane
currents evoked by α, β-meATP (10 µM) and unchanged
ones induced by capsaicin (1 µM) after NGF application.
The histograms in Fig. 8B b summarize these data, indicat-
ing that chronically-applied NGF could selectively upreg-
ulate P2X3 receptor function with no significant change in
the amplitude of capsaicin-induced currents. The lack of
change in TRPV1 receptor mediated responses was not
attributable to inability of the present cultures to show
upregulation of capsaicin-induced responses by NGF. In
fact, acutely applied NGF (50 ng/ml for 5 min) could
Receptor co-localization investigated with double immun-ofluorescenceFigu  4
Receptor co-localization investigated with double 
immunofluorescence. Percent of neurons showing double 
immunoreactivity for pairs of P2X3, P2X2 and TRPV1 as indi-
cated (rat data are on the left while mouse ones are on the 
right). The "reference" receptor type is taken as 100%. Data 
from ganglia (about 1,000 neurons) or at different d in cul-
ture (about 500 cells per culture) are shown with differently 
shaded histograms. n = 3 animals for each bar. *: P < 0.05. 
Values at later d in culture are also significantly different from 
ganglia. Further details are in the legend to Fig. 3.Page 7 of 15
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induced by small concentrations of capsaicin (0.1 µM).
Chronically-applied 5-HT selectively upregulated TRPV1 
receptors
The differential upregulation of P2X3 and TRPV1 receptors
in culture by NGF begged the question whether other
mediators believed to be involved in headache might
elicit similar long-lasting changes. Since short application
of 5-HT has no action on P2X3 receptors [30], we investi-
gated the effect of 5-HT (10 µM; [31]) applied for 24 h to
rat TG neurons. Figure 8C a shows typical examples of α,
β-meATP (10 µM)- or capsaicin (10 µM)- induced cur-
rents obtained in control or after treatment with 5-HT.
Note that, while the α, β-meATP response was essentially
the same, the response to capsaicin grew much larger. This
phenomenon was statistically significant as indicated in
Fig. 8C.
Discussion
By combining morphology, molecular biology, immuno-
cytochemistry, Ca2+ imaging and electrophysiology, the
current study provides the novel characterization of the
expression, time-profile and function of P2X and TRPV1
receptors on rat or mouse TG neurons in culture. Compar-
ing TG ganglia and cultures had not been done before and
allowed us to discern distinctive changes in key pain trans-
ducing molecules in a species-dependent fashion and to
monitor their early adaptive changes in vitro, thus demon-
strating limits as well as usefulness of the model. Further-
more, the differential upregulation of P2X3 and TRPV1
receptors observed after chronically applying either NGF
or 5-HT suggested diversity in adapting pain signaling sys-
tems to algogenic substances.
Expression of P2X and TRPV1 receptors in ganglia and 
culture
Our culture conditions ensured that small and medium
size neurons, normally associated with pain transducing
function [21], were the largest population, in analogy
with observations on sections of trigeminal ganglia. One
important question was whether cultured TG neurons
expressed P2X and TRPV1 receptors like those found in
tissue sections of the TG. To the best of our knowledge,
this issue has not been investigated before by directly
comparing these markers in ganglion sections and in TG
cultures.
Real time RT-PCR and Western blot analysis indicated that
there was a significant increase in TRPV1 and P2X3 recep-
tors in culture with little change for P2X2 receptors. In
addition, the emergence of immature forms of P2X3 recep-
tors may suggest neosynthesis and trafficking of these pro-
teins to reflect ongoing plasticity. Although both RT-PCR
and Western blot yielded unidirectional results, we
observed a mismatch in the timecourse of RT-PCR and
Western blot signals for TRPV1 receptors. A discrepancy
between transcription and translation is not an uncom-
Calcium imaging indicates functional expression of P2X and TRPV1 receptorsFigure 5
Calcium imaging indicates functional expression of 
P2X and TRPV1 receptors. A, examples of Ca2+ tran-
sients in mouse TG neurons activated by 2 s application of 10 
µM α, β-meATP or 1 µM capsaicin. a, example of cell 
responding to α, β-meATP only ('purinergic phenotype'); b, 
responding to capsaicin only ('vanilloid phenotype'); c, 
responding to both agonists ('mixed phenotype'). All cells 
respond to pulse application of KCl. B, number of neurons 
sensitive to α, β-meATP (regardless of their response to cap-
saicin), to capsaicin (regardless of their response to α, β-
meATP) or to both agonists, for mouse (n = 346; left) and rat 
(n = 41; right) TG neurons. Neurons (kept in culture for 24 
h) were identified by their responsiveness to 15 mM KCl (1 
s), while satellite cells and fibroblasts did not respond to this 
agent. Note that the percent of cells responding to capsaicin 
was higher in the rat (55%) than in the mouse (33%).Page 8 of 15
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because of the complex relationship between mRNA and
protein as transcription and translation are governed by
independent mechanisms and separate time constants
[32].
While mouse ganglion P2X immunoreactivity data were
comparable to those by Ruan et al.[33], immunostaining
of cultured neurons showed that, in rat and mouse cul-
tures, the number of cells containing P2X3 and TRPV1
subunits was significantly increased already at 24 h in cul-
ture and remained stable for the following 3 d. Increased
immunoreactivity was, however, absent in the case of
P2X2 receptors.
Co-expression of P2X and TRPV1 receptors was present in
a large number of rat TG neurons, suggesting potential
bimodal signaling to pain stimulants [2,21]. Interestingly,
the small number of neurons immunoreactive for the
P2X2 receptors acquired significant P2X3 receptor immu-
noreactivity in culture. This change in expression profile
might provide the substrate for heteromeric assembly of
P2X2/3 receptors, typically signaling chronic pain [2,5].
Overall, data from real time RT-PCR, Western blotting and
immunocytochemistry suggest upregulation of P2X3 and
TRPV1 receptors in culture with respect to the ganglion.
Intracellular calcium imaging
Measuring responses only from excitable cells which gen-
erated Ca2+ transients to a depolarizing pulse of KCl, we
found the proportion of neurons responsive to α, β-
meATP and the TRPV1 agonist capsaicin similar to the one
obtained with immunocytochemistry data. Ca2+ tran-
sients induced by α, β-meATP comprised Ca2+ influx
partly via open P2X3 receptors and mainly via depolariza-
tion activated Ca2+ channels [34]. The complex nature of
this Ca2+ signal thus accounts for the slow decline of the
α, β-meATP-evoked transients in comparison with the
faster decay of membrane currents generated by the same
agent (Fig. 6A). Our present imaging data thus show that
functional receptors were expressed at membrane level on
the majority of TG neurons.
Membrane currents induced by α, β-meATP or capsaicin
Fast inward currents evoked by α, β-meATP were medi-
ated by P2X3 receptors because of their block by the selec-
tive P2X3 blocker A-317491, and accord with knockout
mouse model data indicating that sensory neurons almost
exclusively express P2X3 and α, β-meATP-insensitive P2X2
receptors [35]. On a significant number of rat TG neurons,
α, β-meATP produced mixed-type currents suggestive of
co-expression of P2X3 and P2X2/3 receptors (the latter
responsible for the residual current component). By using
ATP it was possible to assess the functional role of P2X2
receptors. The amplitude of current responses evoked by
ATP was somewhat larger and more frequently followed
by a slow residual current, suggesting that P2X2 receptors
demonstrated with molecular biology or immunocyto-
chemistry could be functional, although their contribu-
tion to purinergic signaling was quite limited, in
comparison to P2X3 receptors, in terms of response ampli-
tude and percent of neurons expressing them.
Capsaicin-mediated responses were more rarely observed
on mouse neurons than rat ones in accordance with the
low expression level of TRPV1 receptors. Low TRPV1
immunoreactivity is reported also for other murine gan-
glia [36] while high expression is typical of the rat TG [37].
It is likely that, in the mouse, thermal nociception (which
is normally mediated by TRPV1 receptors in the rat) is
transduced, at least in part, by other nociceptive sensor
proteins, in addition to TRPV1 receptors [36,38].
Characteristics of pain receptors of cultured TG neuronsFigure 6
Characteristics of pain receptors of cultured TG neu-
rons. A, examples of currents recorded from rat and mouse 
TG neurons in culture (24 h) during application of α, β-
meATP (10 µM, 2 s; upper row) and capsaicin (10 µM, 2 s for 
rat; 1 µM, 2 s for mouse; bottom row). B, log dose-response 
curves for rat (filled symbols; n = 9) and mouse (grey sym-
bols; n = 12) neurons cultured for 24 h. Both potency and 
efficacy of α, β-meATP were similar for rat and mouse. C, 
distribution of values of the residual current (Iresidual) present 
at the end of an application of α, β-meATP (10 µM, 2 s) in rat 
and mouse neurons cultured for 24 h, expressed as a fraction 
of the peak current (Ipeak; n = 24 and 58 for rat and mouse, 
respectively). Inset shows an example of the mixed type of 
current recorded from a subset of rat TG neurons. Dashed 
line indicates the 5% arbitrary threshold above which cur-
rents were considered to be mixed.Page 9 of 15
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Cultures of sensory neurons are often grown in the pres-
ence of high concentrations of NGF, known to be a strong
algogen operating via multiple metabolic pathways
[1,39]. Our study demonstrated that TG neurons could be
grown in culture without exogenous NGF probably
because the standard medium contained a small concen-
tration of NGF synthesized by cultured cells as shown by
the presence of NGF in homogenates of ganglia and cell
cultures. Since the high-affinity binding of NGF to neuro-
nal membranes has a 0.6 nM dissociation constant [29], it
is probable that, in standard culture conditions, there was
adequate production of NGF to preserve neuronal viabil-
ity. It is likely that other endogenously-produced neuro-
trophins (like for example NT-3, BDNF and GDNF; [40-
42] could also play a role in shaping the activity of these
receptors.
Chronically-applied NGF upregulated the function of
P2X3 receptors without changing TRPV1 receptor activity.
This observation suggests a model system to test how an
excess of NGF expected to occur during certain chronic
pain states can bias the pain transducing properties of
nociceptors towards purinergic rather than vanilloid func-
tion. Such effects by chronic NGF are distinct from the
consequence of acute, brief application of this substance
that enhanced TRPV1 receptor function as previously
reported for DRG neurons [1,43].
5-HT-evoked modulation of TRPV1 receptors
While TG neurons express several types of 5-HT receptors
[44] that can mediate acute nociception via rapid sensiti-
zation of TRPV1 receptors [9], much less is known about
long-term consequences of 24 h exposure to this
monoamine. This is an interesting issue because plasma
levels (in the micromolar range) of 5-HT remain elevated
for many hours during headache [45]. Chronic applica-
tion of 5-HT to TG neurons in culture was followed by a
large upregulation of TRPV1 receptor function without
affecting P2X3 receptors. Because 5-HT induces a large,
long-lasting increase in intracellular Ca2+ [31], it is likely
that Ca2+ dependent changes in second messenger systems
triggered such a plasticity of TRPV1 receptor function.
Conclusion
Primary cultures of TG neurons could be maintained for a
few days without the need of exogenous NGF. This
approach provided a useful preparation to explore how
chronically-applied algogens, implicated in headache
pathophysiology, could generate heightened pain sensi-
tivity. When NGF or 5-HT was tested on such a system,
there was differential modulation of purinergic and vanil-
loid receptors, indicating distinct types of plasticity of
nociceptors depending on the type of algogenic sub-
stance.
Methods
Cell culture preparation of TG neurons
Primary cultures of TG ganglion sensory neurons were
obtained from C57-Black/6Jico mice or Wistar rats (P10–
14; an age reported to show a quasi-adult phenotype for
P2X receptors [33]). Animals were anesthetized by diethyl
ether and decapitated (in accordance with the Italian Ani-
mal Welfare Act and approved by the Local Authority Vet-
erinary Service). TG were rapidly excised and
enzymatically dissociated in F12 medium (Invitrogen
Corp, S.Giuliano Milanese, Italy) containing 0.25 mg/ml
trypsin, 1 mg/ml collagenase and 0.2 mg/ml DNAse
(Sigma) at 37°C. Cells were plated on poly-L-lysine-
coated petri dishes in F12 medium with 10% fetal calf
Functional characterization of rat and mouse TG neuronsigure 7
Functional characterization of rat and mouse TG 
neurons. A, fraction of cells responding to α, β-meATP 
(independently from their response to capsaicin), to capsaicin 
(independently from their response to α, β-meATP) or to 
both agonists for rat (left panel; n = 33) and mouse (right 
panel; n = 50). B, persistence of the responsiveness of rat TG 
neurons in culture to α, β-meATP and capsaicin. a, Propor-
tion of cells responding to α, β-meATP (black bars; n = 7, 7, 
10 cell cultures for the 1st, 2nd and 3rd day, respectively) and 
capsaicin (grey bars; n = 7, 8 and 8 cell cultures for the 1st, 
2nd and 3rd day). b, peak amplitude of currents elicited by α, 
β-meATP (black bars; n = 22, 11 and 31 cells for the 1st, 2nd 
and 3rd day, respectively) and capsaicin (grey bars; n = 16, 13 
and 10 cells for the 1st, 2nd and 3rd day). Only cells responding 
to the agonist were included in the current analysis.Page 10 of 15
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ments, 2 × 106 cells were plated. For patch clamp experi-
ments, mouse and rat cells were diluted twice. Three week-
old TG cultures, that lacked neurons (i.e., negative for the
neuron specific marker β-tubulinIII), served as negative
control for molecular biology experiments.
Real time RT-PCR
For PCR experiments, total RNA was extracted from TG
ganglia or from culture using Trizol reagent (Invitrogen).
After DNAse treatment (Ambion, Austin, TX, USA), cDNA
synthesis and amplification were obtained using Super-
Script III Two-step qRT-PCR kit (Invitrogen). Thirty ng
cDNA were amplified with specific oligonucleotides and
fluorogenic probes (TaqMan gene expression assays,
Applied Biosystems, Applera, Norwalk, CT, USA) in ABI
PRISM 7000 Sequence Detection System (Applied Biosys-
tems) in the presence of ROX (Invitrogen) as internal ref-
erence dye. mRNA samples from fresh ganglia or cultures
at different times were calibrated to obtain similar ampli-
fication of the GAPDH housekeeping mRNA. In prelimi-
nary experiments, analogous amplification of the samples
was obtained also with 18S RNA probes. Nevertheless, to
normalize the real time PCR results only with respect to
neuronal mRNA, amplification of the neuronal specific β-
tubulinIII housekeeping gene was chosen.
Specific TaqMan assays for mouse and rat target mRNA
encoding P2X3, P2X2 and TRPV1, neuronal specific β-
tubulinIII, GAPDH mRNA and 18S RNA (respective
Applied Biosystems catalogue numbers:
Mm00523699_m1, Mm00462952_m1,
Mm01246282_m1, Rn01460299_m1, Mm00727586_s1,
4352339E FG, 4308329; www.appliedbiosystems.com)
were chosen. All assays were validated for linearity of
amplification efficiency and quantitative standard curves
were obtained using serial dilutions of ganglia rat or
mouse TG cDNA. To ensure absence of amplification arti-
facts, end point PCR products were initially assessed on
ethidium bromide-stained agarose gels that gave a single
band of the expected size for each assay. Negative controls
containing no template cDNA were run in each condition
and gave no results. The reactions were quantified when
the PCR product of interest was first detected (cycle
threshold). Calculations for relative mRNA transcript lev-
els were performed using the comparative CT method
(∆∆CT) between cycle thresholds of different reactions
[46]. In particular, the parameter CT (threshold cycle) is
defined as the cycle number at which the fluorescence
emission exceeds the fixed threshold. The calculation is
based on the difference (∆CT) between the CT values of the
target receptor and the neuron-specific housekeeping gene
(β-tubulinIII) at each time-point in culture, and then nor-
malized with respect to the ∆CT value of the ganglion.
Western immunoblot
Rat or mouse TG ganglia or cultures were homogenized in
ice-cold lysis buffer containing 10 mM TrisHCl (pH 7.5),
150 mM NaCl, 20 mM EDTA, 1% Triton X-100, 8 M urea
and protease inhibitors (Roche, Basel, Switzerland). The
procedure was essentially the same as described by Fab-
bretti et al.[47]. The following polyclonal antibodies were
used: P2X3 (1:2000 Neuromics, Bloomington, MN, USA),
P2X2 or TRPV1 (1:400 Alomone, Jerusalem, Israel), β-
tubulinIII (1:400, Chemicon, Temecula, CA, USA). To
ensure correct equal loading reflecting the neuronal cell
content in different lysates, protein extracts were quanti-
fied with bicinchonic acid (Sigma) and calibrated for the
neuronal specific β-tubulinIII. The amount of loaded pro-
teins was in the 20–50 µg/ml range.
Immunocytochemistry
TG ganglion tissue was used with a free-floating immu-
nostaining procedure. TG culture cells were fixed in 4%
paraformaldehyde for 20 min at room temperature. The
following rabbit polyclonal antibodies were used: P2X3
(1:500 from Chemicon), P2X2 and TRPV1 (1:200 from
Alomone), and anti-cleaved caspase3 (1:100, Cell Signal-
ing Technology, Beverly, MA, USA). The mouse mono-
clonal antibodies against the neuron specific β-tubulinIII
(1:100, from Chemicon), GFAP (1:200, Sigma) and JNK
(1:100, Santa Cruz) were used. Immunofluorescence reac-
tions were visualized using the secondary antibodies Alex-
aFluor 488 or AlexaFluor 594 (1:500 dilution; Molecular
Probes, Invitrogen). The P2X3 antibody used for double
immunofluorescence experiments was obtained by
immunizing a guinea-pig with the peptide CVEKQSTDS-
GAYSIGH. The specificity of the guinea-pig anti-P2X3 anti-
body was evaluated by western immunoblotting and
immunofluorescence experiments (dilution 1:500 and
1:200, respectively) of HEK-293 cells transfected with
pCDNA-P2X3 [47]. Tissue or cells stained with the second-
ary antibody only showed no immunostaining. To mini-
mize tissue autofluorescence, TG ganglia were treated with
Sudan Black. All images were captured under the same
brightness and contrast settings. Control experiments
using pre-immune guinea-pig serum gave no signal. In
each experiment the number of positive neurons for a
given antibody was normalized by dividing the number of
positive cells by the number of β-tubulinIII-stained cells
(equal to 100 %). For double immunofluorescence exper-
iments the number of neurons stained with a certain anti-
body was referred as a percent of the total number of cells
stained with the other antibody. An average of 500 cells in
culture or 1,000 cells in the tissue were counted for each
condition. Each data is the mean of at least 3 independent
experiments. Results were analyzed with the ImagePro
Express software (Media Cybernetics, L.P., Silver Spring,
MD, USA).Page 11 of 15
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For scanning electron microscopy, 24 h rat or mouse TG
cultures were fixed in 2.5% glutaraldehyde (Sigma; in 0.1
buffered phosphate; pH 7.3) for 30 min at 4°C and post-
fixed with 1% OsO4 (Sigma), dehydrated in ethanol and
dried by the critical-point method [44]. Ganglia or cul-
tures were sputter-coated with gold (Electron microscopy
sciences, Hatfield, PA, USA) as described [48]. Specimens
were observed under a Stereoscan 430i microscope (Leica,
Houston, TX, USA). Three hundred cells obtained from 4
different rats and 6 mice were observed. Freshly dissected
TGs from two rats were slit open after de-sheathing with-
out enzymatic treatment. Ganglia were fixed for 3 h at 4°C
and treated as above.
ELISA
The level of NGF present in the supernatant or in the cell
lysates of TG culture was assessed with using the Emax
NGF immunoassay system (Promega, Madison, WI,
USA). Rat and mouse TG culture medium was collected
after 24 h from plating and concentrated 4-fold for analy-
sis (n = 4). Furthermore, mouse or rat ganglia or cell cul-
tures were homogenated in 200 µl of a buffer containing
137 mM NaCl, 20 mM TrisHCl (pH 8), 1% NP40, 10%
glycerol and protease inhibitors (Roche). Samples were
diluted (1:6) in the same buffer and processed for ELISA
assay. Results were corrected for blank and normalized. In
the case of ganglia or cells, quantification was normalized
with respect to the genomic DNA content (purified using
GenElute mammalian genomic DNA kit, Sigma). The
recovery of exogenously added NGF (100 ng/ml) was 63
± 11 % (n = 3); data were not corrected for recovery. No
NGF was detected in the fetal calf serum before adding it
to the cultures.
Patch-clamp recording
Cells were continuously superfused (2 ml/min) with
physiological solution containing (in mM): 152 NaCl, 5
KCl, 1 MgCl2, 2 CaCl2, 10 glucose and 10 HEPES (pH
adjusted to 7.4 with NaOH, osmolarity adjusted to 320
mOsm with glucose). Single cells were patch clamped in
the whole-cell configuration using pipettes with a resist-
ance of 3–4 MΩ when filled (in mM) with 140 KCl, 0.5
CaCl2, 2 MgCl2, 2 Mg2ATP3, 2 GTP, 10 HEPES and 10
EGTA (pH adjusted to 7.2 with KOH; osmolarity 285
mOsm). Currents were recorded from medium-sized (15–
25 µm) nociceptive TG neurons [1]. TG cells were voltage
clamped at membrane potential ranging from -70 to -60
mV. Series resistance was compensated by 70 %. α, β-
meATP concentration-response curves were obtained by
applying the same dose range to each tested cell; results
were fitted with a sigmoidal curve (Origin 6.0, Microcal,
Northampton, MA, USA) in order to express agonist
potency in terms of EC50 values (concentration producing
50 % of the maximum response). Each concentration of
Modulation of receptor function by chronically applied NGF or 5-HTFigure 8
Modulation of receptor function by chronically 
applied NGF or 5-HT. A, Ca2+ imaging of single neurons 
shows percent increase in mouse TG cells responsive to α, 
β-meATP (a) in control or after application of 50 ng/ml NGF 
(24 h; n = 6 culture dishes). In 6 sister cultures there was no 
significant change as far as responses to capsaicin (b) were 
concerned. *: P < 0.05. B, a, patch clamp current records 
show increased amplitude of mouse responses to α, β-
meATP after 24 h NGF treatment, while responses to capsa-
icin remained equiamplitude. B, b, histograms summarizing 
the significant (*: P < 0.05) rise in α, β-meATP evoked cur-
rent amplitude (n = 26) without significant change in capsai-
cin responses (n = 14). Data are expressed as % of control 
amplitude in sister cultures. C, 5-HT (10 µM; 24 h) upregu-
lates the amplitude of rat capsaicin current without affecting 
responses to α, β-meATP (a). C,b shows significant rise in 
the peak current induced by capsaicin (n = 31) with no 
change in the α, β-meATP-evoked current (n = 31). Data are 
expressed as % of control amplitude in sister cultures. *: P < 
0.05.Page 12 of 15
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response recovery from desensitization. Capsaicin
induces responses with strong tachyphylaxis during repet-
itive applications [49] and it can kill primary afferent
nociceptors [50]: to circumvent these problems, a single
dose of capsaicin was applied to each TG neuron. On
mouse neurons, 1 µM capsaicin was used as standard test
dose to yield reproducible inward currents, because even
a small increment in concentration (10 µM) produced
very slowly reversible inward currents as previously
reported for sensory neurons [51]. On rat neurons, repro-
ducible responses were evoked with a test (1–10 µM) con-
centration of capsaicin. This concentration is in excess of
the EC50 value for TG neurons [52]. In order to minimize
any possible difference in responses between TG neuron
preparations, sister dishes were used on each occasion to
compare control neurons and neurons treated with 5-HT
or NGF (acute or chronic treatment).
Calcium imaging
Cells were incubated for 40 min at 20–22°C in physiolog-
ical solution containing Fluo3 (AM ester cell-permeable
compound; 5 µM; Molecular Probes), followed by a 30
min washout period. Fluorescence emission was detected
with a fast CCD camera (Coolsnap HQ; Roper Scientific,
Duluth, GA, USA). Images were acquired with 150 ms
exposure time and single cell responses were analysed
with the Metafluor software (Metafluor Imaging Series
6.0, Universal Imaging Corporation, Downingtown, PA,
USA). Intracellular Ca2+ transients were expressed as per-
cent amplitude increase (∆F/F0, where F0 is the baseline
fluorescence level and ∆F is the increment over baseline).
Each event was also visually inspected to exclude artifac-
tual components.
Drug delivery in functional experiments
α, β-meATP, NGF and capsaicin (all from Sigma) were
diluted with physiological solution to final concentration
and applied by a rapid superfusion system (Rapid Solu-
tion Changer RSC-200, BioLogic Science Instruments,
Grenoble, France). The time for solution exchange was
about 30 ms [34]). Chronic application of NGF (50 ng/
ml) was done by applying this substance to TG cultures
for 24 h; cells were patch clamped immediately after
washing out this dose of NGF. Twenty-four hour long
treatment with 5-HT (10 µM) was carried out in the con-
tinuous presence of the monoaminoxidase inhibitor par-
gyline (100 µM; Sigma) to prevent enzymatic breakdown
of this monoamine. Parallel controls were treated with the
same concentration of pargyline alone.
Data analysis
Data are presented as the means ± standard error of the
mean (n = number of cells, unless otherwise indicated).
The statistical significance was assessed with Mann-Whit-
ney rank-sum test and the Wilcoxon test for non paramet-
ric data, and with Student's t-test for parametric data
(KyPlot, version 2.0, Qualest Co., www.qualest.co.jp). For
RT-PCR and Western blot, the films were scanned and
band density was measured using CorelDraw Photopaint
software (Corel, Berkshire, UK), normalized with β-
tubulinIII control band and compared to the tissue value.
For real time PCR, the relative mRNA expression of P2X3,
P2X2 and TRPV1 in the different samples was normalized
to the neuronal β-tubulinIII mRNA content in each condi-
tion and correlated with the one of the TG tissue. These
experiments were performed in duplicate and repeated
thrice for mouse and rat samples. Differences between
groups were compared using ANOVA. A P value of < 0.05
was accepted as indicative of a statistically significant dif-
ference.
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